tirzepatide peptide compound 10mg — GLP-1/GIP Dual-Agonist Research COMPOUNDED TIRZEPATIDE

We view medical weight loss as a restorative tool for long-term biological health, aiming to prevent the cardiovascular and metabolic risks associated with midlife obesity rather than pursuing a superficial fix

& Eisenbarth, G

Usually settles over time and can be improved with micro needling

This includes children with short stature and adults diagnosed with clinically confirmed GHD

Why Brand-Name Cant Match Price Structural Barriers: Public Company Obligations: Must maximize shareholder return Quarterly earnings pressure Executive compensation tied to profits Cant dramatically reduce price without stock impact Sunk Costs: Billions invested in development Need to recoup investment Justify to shareholders and board Complex Distribution System: PBMs demand rebates Wholesalers take cut Pharmacy margins Cant easily change system Market Dynamics: Limited competition (patent protection) Can charge premium prices Demand exceeds supply No pressure to reduce Eli Lilly unlikely to reduce tirzepatide prices significantly while patents protected

Its popularity has grown over the years because it is effective in controlling blood sugar levels and reducing body weight